Indication
HPV-related vulvar intraepithelial neoplasia
1 clinical trial
1 product
Clinical trial
A Phase I Proof-of-Concept Study of Artesunate Ointment for the Treatment of Patients With High-Grade Vulvar Intraepithelial Neoplasia (HSIL VIN 2/3)Status: Active (not recruiting), Estimated PCD: 2022-08-31
Product
Artesunate